Stabilizing the CH2 Domain of an Antibody by Engineering in an Enhanced Aromatic Sequon.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  ACS Chemical Biology

• Publication date

  2016-04-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschembio.5b01035PMID 27128252PMCID PMC4852379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A perspective on the structure and receptor binding properties of immunoglobulin G Fc.

  2015cited by this paper
• Enhanced Aromatic Sequons Increase Oligosaccharyltransferase Glycosylation Efficiency and Glycan Homogeneity.

  2015cited by this paper
• Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding

  2015cited by this paper
• The Structural Role of Antibody N-Glycosylation in Receptor Interactions.

  2015cited by this paper
• Analysis of site-specific N-glycan remodeling in the endoplasmic reticulum and the Golgi.

  2015cited by this paper
• Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists

  2015cited by this paper
• Immunoglobulin G1 Fc domain motions: implications for Fc engineering.

  2014cited by this paper
• Structural basis for selective recognition of endogenous and microbial polysaccharides by macrophage receptor SIGN-R1.

  2014cited by this paper
• Competing aggregation pathways for monoclonal antibodies

  2014cited by this paper
• Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.

  2014cited by this paper
• The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer

  2014cited by this paper
• Structural Determinants of Unique Properties of Human IgG4-Fc

  2014cited by this paper
• Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs

  2013cited by this paper
• Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

  2013cited by this paper
• IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.

  2013cited by this paper
• Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression

  2013cited by this paper
• Structural and energetic basis of carbohydrate-aromatic packing interactions in proteins.

  2013cited by this paper
• Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress

  2013cited by this paper
• Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site

  2013cited by this paper
• Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcγRIIa affinity and selectivity.

  2013cited by this paper
• A fundamental protein property, thermodynamic stability, revealed solely from large-scale measurements of protein function

  2012cited by this paper
• Isotype and glycoform selection for antibody therapeutics.

  2012cited by this paper
• Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis

  2012cited by this paper
• N‐glycosylation of enhanced aromatic sequons to increase glycoprotein stability

  2012cited by this paper
• Revisiting the role of glycosylation in the structure of human IgG Fc.

  2012cited by this paper
• A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

  2011cited by this paper
• NMR Analysis Demonstrates Immunoglobulin G N-glycans are Accessible and Dynamic

  2011cited by this paper
• Classification and Characterization of Therapeutic Antibody Aggregates

  2011cited by this paper
• Glycosylation of the enhanced aromatic sequon is similarly stabilizing in three distinct reverse turn contexts

  2011cited by this paper
• Strategies for extended serum half-life of protein therapeutics.

  2011cited by this paper
• Aggregates in monoclonal antibody manufacturing processes

  2011cited by this paper
• The impact of glycosylation on monoclonal antibody conformation and stability

  2011cited by this paper
• Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

  2011cited by this paper
• Optimizing Therapeutic Antibody Function

  2011cited by this paper
• Structural Basis for FcγRIIa Recognition of Human IgG and Formation of Inflammatory Signaling Complexes

  2011cited by this paper
• Protein Native-State Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse Turns

  2011cited by this paper
• A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin

  2011cited by this paper
• Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.

  2011cited by this paper
• Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.

  2010cited by this paper
• Features and development of Coot

  2010cited by this paper
• Context-dependent effects of asparagine glycosylation on Pin WW folding kinetics and thermodynamics.

  2010cited by this paper
• Design of therapeutic proteins with enhanced stability

  2009cited by this paper
• Glycosylation as a strategy to improve antibody-based therapeutics

  2009cited by this paper
• Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation

  2009cited by this paper
• Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.

  2009cited by this paper
• The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability

  2009cited by this paper
• Aggregation-prone motifs in human immunoglobulin G.

  2009cited by this paper
• Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability.

  2009cited by this paper
• WW: An isolated three‐stranded antiparallel β‐sheet domain that unfolds and refolds reversibly; evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered thermal unfolded state

  2008cited by this paper
• A Perspective on

  2008cited by this paper
• Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.

  2007cited by this paper
• Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.

  2007cited by this paper
• Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies

  2007cited by this paper
• Isotype selection in antibody engineering

  2007cited by this paper
• Phaser crystallographic software

  2007cited by this paper
• Structure-function-folding relationship in a WW domain.

  2006cited by this paper
• Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering.

  2006cited by this paper
• The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport, IgG Homeostasis, and Fate of IgG-Fc-Coupled Drugs1

  2003cited by this paper
• Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

  2003cited by this paper
• Bioequivalence and the immunogenicity of biopharmaceuticals

  2002cited by this paper
• Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design

  2001cited by this paper
• The folding mechanism of a -sheet: the WW domain1

  2001cited by this paper
• High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR*

  2001cited by this paper
• The folding mechanism of a beta-sheet: the WW domain.

  2001cited by this paper
• The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex

  2000cited by this paper
• The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

  2000cited by this paper
• Multiple roles for the major histocompatibility complex class I- related receptor FcRn.

  2000cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice

  1996cited by this paper
• Codon usage limitation in the expression of HIV-1 envelope glycoprotein.

  1996cited by this paper
• Biochemical Applications of Differential Scanning Calorimetry

  1987cited by this paper
• Differential scanning calorimetric study of the thermal unfolding of Taka-amylase A from Aspergillus oryzae.

  1987cited by this paper
• Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

  1981cited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowncited by this paper

• Mapping affinity and allostery in human IgG antibody Fc region-Fc γ receptor interactions

  2025cites this paper
• Comparative Analysis of Glycan Composition in Therapeutic Antibodies via Glycan Profiling and Intact Mass Analysis

  2025cites this paper
• The Biological Basis and Analyses of N-Glycan Microheterogeneity

  2025cites this paper
• Glycosylated Foot‐And‐Mouth Disease Virus‐Like Particles Produced in Pichia Pastoris Enhance Stability and Immunogenicity

  2025cites this paper
• Impact of Glycosylation on Self-Assembled Peptide Hydrogels

  2024cites this paper
• Developability considerations for bispecific and multispecific antibodies

  2024cites this paper
• Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation

  2024cites this paper
• Protein Glycosylation Patterns Shaped By the IRE1-XBP1s Arm of the Unfolded Protein Response.

  2024cites this paper
• Site-Specific Antibody Conjugation Using Modified Bisected N-Glycans: Method Development and Potential toward Tunable Effector Function

  2023cites this paper
• Thermodynamic Stabilization of Human Frataxin

  2023cites this paper
• Structural insight into why S-linked glycosylation cannot adequately mimic the role of natural O-glycosylation.

  2023cites this paper
• Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations

  2023cites this paper
• Decreasing hydrophobicity or shielding hydrophobic areas of CH2 attenuates low pH-induced IgG4 aggregation

  2023cites this paper
• Analysis of Protein Glycosylation after Rapid Digestion Using Protease-Containing Membranes in Spin Columns.

  2023cites this paper
• Asn57 N-glycosylation promotes the degradation of hemicellulose by β-1,3–1,4-glucanase from Rhizopus homothallicus

  2022cites this paper
• Structural Dynamics of a Thermally Stressed Monoclonal Antibody Characterized by Temperature-Dependent H/D Exchange Mass Spectrometry.

  2022cites this paper
• Chemico-Pharmacological Screening of the Methanol Extract of Gynura nepalensis D.C. Deciphered Promising Antioxidant and Hepatoprotective Potentials: Evidenced from in vitro, in vivo, and Computer-Aided Studies

  2022cites this paper
• Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and N-Glycosylated Antibodies

  2022cites this paper
• Chemical (neo)glycosylation of biological drugs.

  2021cites this paper
• Glycoengineering Chinese hamster ovary cells: a short history

  2021cites this paper
• Glycan–protein interactions determine kinetics of N-glycan remodeling

  2021cites this paper
• Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?

  2021cites this paper
• Ganoderma applanatum mushroom provides new insights into the management of diabetes mellitus, hyperlipidemia, and hepatic degeneration: A comprehensive analysis

  2021cites this paper
• Glycan-Protein Interactions Determine Kinetics of N-Glycan Remodeling

  2020cites this paper
• Highly sensitive HPLC analysis and biophysical characterization of N‐glycans of IgG‐Fc domain in comparison between CHO and 293 cells using FcγRIIIa ligand

  2020influential citation
• Experimental and Modeling Framework for the Production of Cell and Protein-Based Biopharmaceutical Products

  2019cites this paper
• Optimization of the C-terminus of an autonomous human IgG1 CH2 domain for stability and aggregation resistance.

  2019cites this paper
• Assessing localized conformational stability of antibody-drug conjugate by protein conformation assay.

  2019cites this paper
• An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding

  2019cites this paper
• The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins.

  2019cites this paper
• A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function.

  2019cites this paper
• Recent advances in enhanced enzyme activity, thermostability and secretion by N-glycosylation regulation in yeast

  2018cites this paper
• An oligosaccharyltransferase from Leishmania major increases the N‐glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana

  2018cites this paper
• Recent advances in enhanced enzyme activity, thermostability and secretion by N-glycosylation regulation in yeast

  2018cites this paper
• Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment

  2018influential citation
• The contributions of individual galactosyltransferases to protein specific N-glycan processing in Chinese Hamster Ovary cells.

  2018cites this paper
• Using Chemical Synthesis To Study and Apply Protein Glycosylation.

  2018cites this paper
• O-GalNAcylation of RANTES Improves Its Properties as a Human Immunodeficiency Virus Type 1 Entry Inhibitor.

  2018cites this paper
• Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics

  2018cites this paper
• Design of Glyco-Linkers at Multiple Structural Levels to Modulate Protein Stability.

  2018cites this paper
• Heat denaturation of the antibody, a multi-domain protein

  2017cites this paper
• Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity.

  2017cites this paper
• Glycosylation of IgG-Fc: a molecular perspective

  2017cites this paper
• Therapeutic monoclonal antibody N-glycosylation - Structure, function and therapeutic potential.

  2017cites this paper
• Influence of protein/glycan interaction on site‐specific glycan heterogeneity

  2017cites this paper
• Stabilizing two IgG1 monoclonal antibodies by surfactants: Balance between aggregation prevention and structure perturbation

  2017cites this paper
• Optimization on Fc for Improvement of Stability and Aggregation Resistance.

  2016cites this paper
• Antibody Aggregation: Insights from Sequence and Structure

  2016cites this paper